Shenzhen Salubris Pharmaceuticals Co

Shenzhen Salubris Pharmaceuticals Co 

Shenzhen Salubris Pharmaceuticals Co is a comprehensive pharmaceutical company that integrates pharmaceutical products research and development, production, and business sales. It was founded in 1998 and listed on the Shenzhen Stock Exchange in 2009.

Salubris has been selected as one of the Top 20 Chinese Competitive Medicine Listed Companies multiple times since 2013. In 2017 and 2018, it was selected as one of the Top 10 Chinese R&D Innovation Pharmaceutical Listed Companies. Salubris lays out its global industrial chain in more than 30 countries and regions, including China, USA, Germany, France, and Japan.

The company's business focuses on the therapeutic fields of cardiovascular, anti-diabetic, antineoplastic, and orthopedic treatments, as well as three mainlines of high-end chemical medicine, innovative biological medicine, and medical apparatus and instruments, forming a strategic synergy between products.

In the future, Salubris will focus on patients and pursue the improvement of products to increase customer satisfaction. With their differentiated competitive advantages, Salubris will gradually become a China-based international innovative pharmaceutical enterprise. 

Add: 37F, Building B, NEO Lvjing Square, 6009 Shennan Avenue, Futian District, Shenzhen, Guangdong Province

Tel: 0755-83867888